By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...

Moderna Inc. MRNA on Friday reported a fourth-quarter loss of $2.11, beating the expected loss of $2.59, lower than a loss of $2.91 a year ago. The COVID-19 vaccine maker reported quarterly sales of ...

Q4 2025 earnings call highlights: revenue, cost cuts, cash outlook, FDA flu setback, and 2026 growth guidance—read key insights now.

By Hugo Francisco de Souza Inside the rigorous, step-by-step process the CDC uses to create pandemic-ready flu vaccine ...